A. Alev Gerçeker
- Molecular Biology
- Microbiology top 5%
- Pulmonary and Respiratory Medicine
- Molecular Medicine top 5%
- Food Science
- Co-authors
- Sibel DöşlerGerald B. PierElif KaraaslanÇagla Bozkurt-GüzelDavid E. GolanPatrick W. YaconoTorsten H. SchroederCarolyn L. Cannon
- Topics
- Antimicrobial Peptides and Activities (5 papers)Antibiotic Resistance in Bacteria (4 papers)Cystic Fibrosis Research Advances (4 papers)
- Journals
- Proceedings of the National Academy of SciencesInfection and ImmunityJournal of Antimicrobial Chemotherapy
- Partner nations
- TürkiyeUnited StatesGermany
In The Last Decade
A. Alev Gerçeker
14 papers receiving 451 citations
Peers
Comparison fields: 5 of 74
- Molecular Biology 217
- Microbiology 135
- Pulmonary and Respiratory Medicine 94
- Molecular Medicine 94
- Food Science 66
Countries citing papers authored by A. Alev Gerçeker
This map shows the geographic impact of A. Alev Gerçeker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Alev Gerçeker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Alev Gerçeker more than expected).
Fields of papers citing papers by A. Alev Gerçeker
This network shows the impact of papers produced by A. Alev Gerçeker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Alev Gerçeker. The network helps show where A. Alev Gerçeker may publish in the future.
Co-authorship network of co-authors of A. Alev Gerçeker
This figure shows the co-authorship network connecting the top 25 collaborators of A. Alev Gerçeker. A scholar is included among the top collaborators of A. Alev Gerçeker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Alev Gerçeker. A. Alev Gerçeker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 77 | |
| 2 | 56 | |
| 3 | 2 | |
| 4 | 57 | |
| 5 | 12 | |
| 6 | 22 | |
| 7 | 15 | |
| 8 | 120 | |
| 9 | 20 | |
| 10 | In vivo studies on nasal preparations of ciprofloxacin hydrochloride. | 23 |
| 11 | 1 | |
| 12 | 22 | |
| 13 | Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. | 16 |
| 14 | 24 |
About A. Alev Gerçeker
A. Alev Gerçeker is a scholar working on Microbiology, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 14 papers that have together received 467 indexed citations. Recurring topics across this work include Antimicrobial Peptides and Activities (5 papers), Antibiotic Resistance in Bacteria (4 papers) and Cystic Fibrosis Research Advances (4 papers). The work is most often cited by research in Microbiology (135 citations), Molecular Medicine (94 citations) and Applied Microbiology and Biotechnology (13 citations). A. Alev Gerçeker has collaborated with scholars based in Türkiye, United States and Germany. Frequent co-authors include Sibel Döşler, Gerald B. Pier, Elif Karaaslan, Çagla Bozkurt-Güzel, David E. Golan, Patrick W. Yacono, Torsten H. Schroeder, Carolyn L. Cannon, Bulent Gürler and M J Preston. Their work appears in journals such as Proceedings of the National Academy of Sciences, Infection and Immunity and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.